| abstract |
The present invention provides a tyrosine kinase inhibitor, particularly a Bruton tyrosine kinase ("BTK") inhibitor, and is therefore suitable for treating diseases which can be treated by inhibiting BTK (such as cancer, self Compounds of body immunity, inflammation, and thromboembolic disease. Pharmaceutical compositions containing such compounds and methods of preparing such compounds are also provided. |